Opdivo (nivolumab) 100 mg, Bristol Myers Squibb, USA, original Opdivo (nivolumab) is used for approved oncology indications including unresectable or metastatic melanoma. Medicine delivery from Europe. Contact +380996042415.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Indications
Opdivo (nivolumab) is a drug for the treatment of patients with inoperable or metastatic melanoma in the presence of melanoma, the course of which is accompanied by a mutation of the BRAF gene, if the use of BRAF inhibitors does not bring the expected results effect; for the treatment of patients with metastatic squamous cell progressive lung cancer. Treatment with nivolumab is carried out under the supervision of the attending physician, who determines its dosage and frequency of administration, based on current standard treatment protocols. If significant Adverse reactions occur, the doctor may discontinue the drug or adjust the dosage.
Analogues: there are no known analogues.
- Trade name:Opdivo
- Chemical name:Nivolumab
- Dosage:100 mg
- Quantity:1
- Dosage form:Ampoule
- Manufacturer:Bristol Myers Squibb
No reviews yet
